Dana Inc/ US2358252052 /
31/05/2024 21:59:59 | Chg. +0.17 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
14.06USD | +1.22% | 20,944 Turnover: 293,524.31 |
-Bid Size: - | -Ask Size: - | 2.04 bill.USD | 2.85% | 54.08 |
GlobeNewswire
16:00
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
28/05
LiquidStack to Showcase Immersion Cooling Technology at Cisco Live's Sustainability Zone
GlobeNewswire
23/05
Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluatin...
GlobeNewswire
20/05
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponso...
GlobeNewswire
15/05
Pacific Software Inc. Secures Strategic License Agreement with the University of California for Inno...
GlobeNewswire
13/05
Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Confere...
GlobeNewswire
10/05
Open Space Institute Holds 50th Anniversary Gala Honoring Founders John & Patricia Adams and Longtim...
GlobeNewswire
09/05
Konica Minolta’s Jason Dizzine and Dana Drury Named as ENX Magazine 2024 Difference Makers
GlobeNewswire
08/05
LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activatio...
GlobeNewswire
06/05
Pacific Software Inc. Announces a Landmark Asset Acquisition from Dreamaderm Inc.
GlobeNewswire
29/04
Wabash Recognized with Two Plant Safety Awards at Mexico and Kentucky Operations
GlobeNewswire
26/04
SAMUEL ADAMS TAPPED AS THE OFFICIAL BEER AND NON-ALCOHOLIC BEER OF THE PAN-MASS CHALLENGE